Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1995 2
1996 2
1997 2
1998 2
1999 3
2000 2
2001 2
2002 3
2003 2
2004 1
2005 4
2006 3
2007 1
2008 4
2009 6
2010 7
2011 3
2012 11
2013 8
2014 8
2015 5
2016 5
2017 6
2018 3
2019 6
2020 2
2021 8
2022 10
2023 2
2024 8
2025 10
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
Bidulka P, Lugo-Palacios DG, Carroll O, O'Neill S, Adler AI, Basu A, Silverwood RJ, Bartlett JW, Nitsch D, Charlton P, Briggs AH, Smeeth L, Douglas IJ, Khunti K, Grieve R. Bidulka P, et al. Among authors: adler ai. BMJ. 2024 May 8;385:e077097. doi: 10.1136/bmj-2023-077097. BMJ. 2024. PMID: 38719492 Free PMC article.
The diabetes prevention program.
Adler AI, Turner RC. Adler AI, et al. Diabetes Care. 1999 Apr;22(4):543-5. doi: 10.2337/diacare.22.4.543. Diabetes Care. 1999. PMID: 10189529 Review. No abstract available.
Insulin resistance and incident heart failure: a meta-analysis.
Erqou S, Adler AI, Challa AA, Fonarow GC, Echouffo-Tcheugui JB. Erqou S, et al. Among authors: adler ai. Eur J Heart Fail. 2022 Jun;24(6):1139-1141. doi: 10.1002/ejhf.2531. Epub 2022 May 16. Eur J Heart Fail. 2022. PMID: 35502564 Free PMC article. No abstract available.
Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults.
Koychev I, Adler AI, Edison P, Tom B, Milton JE, Butchart J, Hampshire A, Marshall C, Coulthard E, Zetterberg H, Hellyer P, Cormack F, Underwood BR, Mummery CJ, Holman RR. Koychev I, et al. Among authors: adler ai. BMJ Open. 2024 Jun 21;14(6):e081401. doi: 10.1136/bmjopen-2023-081401. BMJ Open. 2024. PMID: 38908839 Free PMC article.
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
Nazarzadeh M, Bidel Z, Canoy D, Copland E, Bennett DA, Dehghan A, Davey Smith G, Holman RR, Woodward M, Gupta A, Adler AI, Wamil M, Sattar N, Cushman WC, McManus RJ, Teo K, Davis BR, Chalmers J, Pepine CJ, Rahimi K; Blood Pressure Lowering Treatment Trialists' Collaboration. Nazarzadeh M, et al. Among authors: adler ai. Lancet Diabetes Endocrinol. 2022 Sep;10(9):645-654. doi: 10.1016/S2213-8587(22)00172-3. Epub 2022 Jul 22. Lancet Diabetes Endocrinol. 2022. PMID: 35878651 Free PMC article.
130 results